SH Scilex Holding Co Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Scilex Holding Co stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €45m. The latest transaction was filed on 7 July 2026 (J). Among the most active insiders: SHAH JAISIM. The full history is openly available.
€280,664
14 ops.
Buy Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
● 10% Owner · Executives · 3 Jul 2026
500,000 shares Common stock SEC:0001193125-26-297858:0
3,689,016 shares @ US$0.7509 100.0% of flow Common Stock SEC:0001193125-25-337437:0
3,250,000 shares Common Stock SEC:0000950170-25-008463:0
779,371 shares Common Stock SEC:0000950170-25-006876:0
5,000,000 shares Common Stock SEC:0000950170-25-002437:0
▲ See Remarks · Executives · 18 Dec 2024
30,000 shares @ US$0.46 6.6% of flow Common Stock SEC:0000950170-24-138066:0
Canonical exit: 18 Mar 2025 (T+90) ▲ Executive Chairperson · Executives · 31 Oct 2024
8,888 shares @ US$0.9396 8.8% of flow Common Stock SEC:0000950170-24-119394:0
Canonical exit: 29 Jan 2025 (T+90) ▲ See Remarks · Executives · 29 Oct 2024
32,000 shares @ US$0.9897 14.6% of flow Common Stock SEC:0000950170-24-118435:0
Canonical exit: 27 Jan 2025 (T+90) ▲ Director · Executives · 17 Oct 2024
2,000 shares @ US$0.90 100.0% of flow Common Stock SEC:0000950170-24-115450:0
Canonical exit: 15 Jan 2025 (T+90) ▲ Director · Executives · 18 Oct 2024
5,000 shares @ US$0.95 7.5% of flow Common Stock SEC:0000950170-24-115629:0
Canonical exit: 16 Jan 2025 (T+90) ▲ Director · Executives · 17 Oct 2024
20,000 shares @ US$0.9496 72.7% of flow Common Stock SEC:0000950170-24-115452:0
Canonical exit: 15 Jan 2025 (T+90) ▲ Executive Chairperson · Executives · 17 Oct 2024
10,000 shares @ US$0.971 10.3% of flow Common Stock SEC:0000950170-24-115449:0
Canonical exit: 15 Jan 2025 (T+90) ▲ Director · Executives · 18 Oct 2024
1,000 shares @ US$0.99 41.6% of flow Common Stock SEC:0000950170-24-115630:0
Canonical exit: 16 Jan 2025 (T+90) ▲ See Remarks · Executives · 16 Oct 2024
30,000 shares @ US$0.9917 13.7% of flow Common Stock SEC:0000950170-24-115226:0
Canonical exit: 14 Jan 2025 (T+90) ▲ Chief Financial Officer · Executives · 16 Oct 2024
6,700 shares @ US$0.97 29.8% of flow Common Stock SEC:0000950170-24-115199:0
Canonical exit: 14 Jan 2025 (T+90) ◇ Director · Executives · 26 Jun 2024
1,000 shares @ US$1.37 58.4% of flow Common Stock SEC:0000950170-24-078116:0
◇ See Remarks · Executives · 20 Jun 2024
14,000 shares @ US$1.73 11.3% of flow Common Stock SEC:0000950170-24-075656:0
◇ Chief Financial Officer · Executives · 20 Jun 2024
2,000 shares @ US$1.41 13.1% of flow Common Stock SEC:0000950170-24-075674:0
◇ Director · Executives · 20 Jun 2024
5,000 shares @ US$1.41 27.3% of flow Common Stock SEC:0000950170-24-075773:0
◇ Director · Executives · 20 Jun 2024
5,000 shares @ US$1.41 11.3% of flow Common Stock SEC:0000950170-24-075669:0
◇ Executive Chairperson · Executives · 18 Jun 2024
6,000 shares @ US$1.41 9.0% of flow Common Stock SEC:0000950170-24-075213:0
◇ See Remarks · Executives · 14 Jun 2024
33,333 shares @ US$1.41 21.8% of flow Common Stock SEC:0000950170-24-073618:0
▲ Chief Financial Officer · Executives · 17 May 2024
14,140 shares @ US$0.88 57.1% of flow Common Stock SEC:0000950170-24-061690:0
Canonical exit: 15 Aug 2024 (T+90) ▲ Executive Chairperson · Executives · 17 May 2024
50,000 shares @ US$0.8797 46.5% of flow Common Stock SEC:0000950170-24-062009:0
Canonical exit: 15 Aug 2024 (T+90) ▲ Director · Executives · 17 May 2024
57,500 shares @ US$0.8981 81.2% of flow Common Stock SEC:0000950170-24-062008:0
Canonical exit: 15 Aug 2024 (T+90) 25 of 29 declarations
Load more (4 remaining) 关于 Scilex Holding Co Scilex Holding Co 是一家在 XNAS 市场上市的公司，专注于开发疼痛管理疗法。它旨在提供创新解决方案以提高患者的生活质量。